Vivos Therapeutics, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Vivos Therapeutics, Inc. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $72.00K.
- Vivos Therapeutics, Inc. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $514.00K.
- Vivos Therapeutics, Inc. stock issued during period, value, issued for services for the quarter ending 2024-06-30 was $14.00K.
- Vivos Therapeutics, Inc. stock issued during period, value, issued for services for the quarter ending 2022-06-30 was $131.00K.
- Vivos Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2024 was $11.00K, a 98.67% decline from fiscal 2023.
- Vivos Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2023 was $824.00K, a 15.89% increase from fiscal 2022.
- Vivos Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2022 was $711.00K, a 3455.00% increase from fiscal 2021.
- Vivos Therapeutics, Inc. stock issued during period, value, issued for services for fiscal 2021 was $20.00K, a 97.05% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $72.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $514.00K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $11.00K 10-K · filed 2026-04-15 | |
| 2024-06-30 | $14.00K 10-Q · filed 2025-11-19 | |
| 2023-12-31 | $824.00K 10-K/A · filed 2024-07-30 | |
| 2022-12-31 | $711.00K 10-K · filed 2023-03-30 | |
| 2022-06-30 | $131.00K 10-Q · filed 2023-08-16 | |
| 2022-03-31 | $222.00K 10-Q · filed 2023-08-16 | |
| 2021-12-31 | $20.00K 10-K · filed 2023-03-30 | |
| 2021-03-31 | $20.00K 10-Q · filed 2022-12-20 | |
| 2020-12-31 | $677.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $15.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $250.00K 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $187.50K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |